Citizens Jmp Cuts Bowhead Specialty (NYSE:BOW) Price Target to $35.00
by Renee Jackson · The Cerbat GemBowhead Specialty (NYSE:BOW – Get Free Report) had its price target decreased by equities researchers at Citizens Jmp from $38.00 to $35.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “market outperform” rating on the stock. Citizens Jmp’s price target suggests a potential upside of 45.41% from the stock’s current price.
A number of other brokerages have also recently weighed in on BOW. Weiss Ratings reiterated a “hold (c-)” rating on shares of Bowhead Specialty in a report on Friday, March 27th. Zacks Research upgraded Bowhead Specialty from a “strong sell” rating to a “hold” rating in a report on Tuesday, February 24th. Keefe, Bruyette & Woods upgraded Bowhead Specialty from a “moderate buy” rating to a “strong-buy” rating in a report on Monday, March 16th. Piper Sandler lifted their target price on Bowhead Specialty from $30.00 to $32.00 and gave the company an “overweight” rating in a report on Monday, December 22nd. Finally, Morgan Stanley reduced their target price on Bowhead Specialty from $27.00 to $25.00 and set an “equal weight” rating on the stock in a report on Monday, April 6th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, Bowhead Specialty has a consensus rating of “Moderate Buy” and a consensus target price of $31.83.
Get Our Latest Research Report on Bowhead Specialty
Bowhead Specialty Price Performance
BOW stock opened at $24.07 on Monday. Bowhead Specialty has a 52-week low of $21.21 and a 52-week high of $41.98. The stock’s fifty day simple moving average is $23.68 and its 200-day simple moving average is $25.38. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $790.46 million, a price-to-earnings ratio of 15.14, a price-to-earnings-growth ratio of 0.72 and a beta of -0.49.
Bowhead Specialty (NYSE:BOW – Get Free Report) last posted its quarterly earnings data on Tuesday, February 24th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.02. Bowhead Specialty had a return on equity of 13.27% and a net margin of 9.75%.The business had revenue of $151.68 million for the quarter, compared to analysts’ expectations of $145.99 million. Equities research analysts expect that Bowhead Specialty will post 1.36 EPS for the current year.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. Y Intercept Hong Kong Ltd raised its position in Bowhead Specialty by 47.3% in the third quarter. Y Intercept Hong Kong Ltd now owns 133,958 shares of the company’s stock valued at $3,622,000 after purchasing an additional 43,029 shares during the period. DAVENPORT & Co LLC raised its position in Bowhead Specialty by 205.7% in the third quarter. DAVENPORT & Co LLC now owns 269,769 shares of the company’s stock valued at $7,295,000 after purchasing an additional 181,531 shares during the period. Victory Capital Management Inc. raised its position in Bowhead Specialty by 54.3% in the third quarter. Victory Capital Management Inc. now owns 1,525,285 shares of the company’s stock valued at $41,244,000 after purchasing an additional 536,817 shares during the period. Lighthouse Investment Partners LLC raised its position in Bowhead Specialty by 138.1% in the third quarter. Lighthouse Investment Partners LLC now owns 208,655 shares of the company’s stock valued at $5,642,000 after purchasing an additional 121,037 shares during the period. Finally, American Century Companies Inc. raised its position in Bowhead Specialty by 73.3% in the third quarter. American Century Companies Inc. now owns 1,412,408 shares of the company’s stock valued at $38,192,000 after purchasing an additional 597,191 shares during the period.
About Bowhead Specialty
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.